Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -77.83% is 20% below its 5-year average of -64.91%, near the high end of its 5-year range (-645.89%–59.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.97% above its 12-month average of -105.13%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -77.83%.
RETURN ON EQUITY (ROE)
-77.83%
RETURN ON EQUITY (ROE) AVG TTM
-105.13%
RETURN ON EQUITY (ROE) AVG 3Y
-207.03%
RETURN ON EQUITY (ROE) AVG 5Y
-64.91%
RETURN ON EQUITY (ROE) AVG 10Y
-59.93%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.97%
CURRENT VS 3Y AVG
+62.41%
CURRENT VS 5Y AVG
-19.91%
CURRENT VS 10Y AVG
-29.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-85.27%
vs the sector median at left
uniQure N.V.
Market Cap
$1.61B
Return on Equity (ROE)
-77.83%
TTM Avg
-105.13%
3Y Avg
-207.03%
5Y Avg
-64.91%
Market Cap
$1.62B
Return on Equity (ROE)
-6.27%
TTM Avg
-14.95%
3Y Avg
-10.20%
5Y Avg
-10.20%
Market Cap
$1.60B
Return on Equity (ROE)
-57.97%
TTM Avg
-51.00%
3Y Avg
-97.84%
5Y Avg
-100.56%
Market Cap
$1.61B
Return on Equity (ROE)
3.03%
TTM Avg
0.59%
3Y Avg
-0.01%
5Y Avg
1.68%
Market Cap
$1.62B
Return on Equity (ROE)
N/A
TTM Avg
-1058.20%
3Y Avg
-465.87%
5Y Avg
-348.95%
Market Cap
$1.59B
Return on Equity (ROE)
-67.40%
TTM Avg
-53.05%
3Y Avg
2.62%
5Y Avg
2.10%
Market Cap
$1.63B
Return on Equity (ROE)
17.72%
TTM Avg
5.08%
3Y Avg
0.03%
5Y Avg
-3.88%
Market Cap
$1.56B
Return on Equity (ROE)
-60.17%
TTM Avg
-20.40%
3Y Avg
-40.27%
5Y Avg
-36.46%
Market Cap
$1.54B
Return on Equity (ROE)
28.97%
TTM Avg
13.25%
3Y Avg
22.73%
5Y Avg
32.77%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| uniQure N.V. (QURE) | $1.61B | -77.83% | -105.13% | -207.03% | -64.91% |
| Septerna Inc (SEPN)vs › | $1.62B | -6.27% | -14.95% | -10.20% | -10.20% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.60B | -57.97% | -51.00% | -97.84% | -100.56% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 3.03% | 0.59% | -0.01% | 1.68% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | N/A | -1058.20% | -465.87% | -348.95% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -67.40% | -53.05% | 2.62% | 2.10% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 17.72% | 5.08% | 0.03% | -3.88% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.56B | -60.17% | -20.40% | -40.27% | -36.46% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 28.97% | 13.25% | 22.73% | 32.77% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.53B | -1462.12% | -276.13% | -155.50% | -107.48% |
ROE
-77.8%
ROA
-25.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -77.83% |
| 2026-03-31 | -139.86% |
| 2025-12-31 | -100.04% |
| 2025-09-30 | -102.80% |
| 2025-03-31 | -645.89% |
| 2024-09-30 | -429.05% |
| 2024-06-30 | -293.18% |
| 2024-03-31 | -202.29% |
| 2023-12-31 | -148.54% |
| 2023-09-30 | -85.00% |
| 2023-06-30 | -52.86% |
| 2023-03-31 | -38.12% |
| 2022-12-31 | -26.64% |
| 2022-09-30 | -29.77% |
| 2022-06-30 | -23.45% |
| 2022-03-31 | 59.43% |
| 2021-12-31 | 55.32% |
| 2021-09-30 | 54.28% |
| 2021-06-30 | 47.89% |
| 2021-03-31 | -60.60% |
| 2020-12-31 | -51.26% |
| 2020-09-30 | -72.73% |
| 2020-06-30 | -51.06% |
| 2020-03-31 | -42.16% |
| 2019-12-31 | -38.45% |
| 2019-09-30 | -29.88% |
| 2019-06-30 | -78.07% |
| 2019-03-31 | -58.74% |
| 2018-12-31 | -46.38% |
| 2018-09-30 | -44.48% |
| 2018-06-30 | -35.30% |
| 2018-03-31 | -77.57% |
| 2017-12-31 | -88.70% |
| 2017-09-30 | -332.64% |
| 2017-06-30 | -257.07% |
| 2017-03-31 | -153.91% |
| 2016-12-31 | -115.39% |
| 2016-09-30 | -90.62% |
| 2016-06-30 | -92.21% |
| 2016-03-31 | -75.96% |
| 2015-12-31 | -59.36% |
| 2015-09-30 | -51.88% |
| 2015-06-30 | -44.47% |
| 2015-03-31 | -135.75% |
| 2014-12-31 | -89.20% |
| 2014-09-30 | -67.71% |
| 2014-06-30 | -55.66% |
| 2014-03-31 | -46.72% |
| 2013-12-31 | -464.99% |
| 2013-09-30 | -211.66% |
